Reports for SANDOZ CANADA INCORPORATED
Company Name
SANDOZ CANADA INCORPORATED
Totals |
||
Shortage reports |
2266 |
|
| Actual shortage: | 50 (2%) | |
| Anticipated shortage: | 0 (0%) | |
| Avoided shortage: | 19 (1%) | |
| Resolved: | 2197 (97%) | |
Discontinuation Reports |
124 |
|
| To be discontinued: | 4 (3%) | |
| Discontinued: | 118 (95%) | |
| Reversed: | 2 (2%) | |
Late reports |
451 (19%) |
|
Overdue reports |
11 (20%) |
|
Shortage reports
| Brand name | Strength | Dosage | Status | Date Created | Date Updated | Reports |
|---|---|---|---|---|---|---|
| SANDOZ AMLODIPINE | 5MG | TABLET | Resolved | 2023-04-21 | 2023-05-03 | 190130 |
| SANDOZ AMLODIPINE | 10MG | TABLET | Resolved | 2023-05-01 | 2023-05-25 | 191369 |
| SANDOZ AMLODIPINE | 5MG | TABLET | Resolved | 2023-06-12 | 2023-07-11 | 194746 |
| SANDOZ AMLODIPINE | 5MG | TABLET | Resolved | 2023-07-17 | 2023-07-25 | 198805 |
| SANDOZ AMLODIPINE | 5MG | TABLET | Resolved | 2023-08-14 | 2023-09-06 | 201722 |
| SANDOZ AMLODIPINE | 5MG | TABLET | Resolved | 2023-08-14 | 2023-08-30 | 201725 |
| SANDOZ AMLODIPINE | 10MG | TABLET | Resolved | 2023-08-21 | 2023-08-29 | 202533 |
| SANDOZ AMLODIPINE | 2.5MG | TABLET | Resolved | 2023-10-02 | 2023-10-11 | 205778 |
| SANDOZ AMLODIPINE | 5MG | TABLET | Resolved | 2024-05-13 | 2024-06-04 | 227841 |
| SANDOZ AMLODIPINE | 5MG | TABLET | Resolved | 2024-07-08 | 2024-07-16 | 232465 |
| SANDOZ AMLODIPINE | 10MG | TABLET | Resolved | 2025-06-16 | 2025-07-01 | 260345 |
| SANDOZ AMOXI-CLAV TABLET | 125MG 500MG | TABLET | Resolved | 2023-06-05 | 2023-06-13 | 193693 |
| SANDOZ AMOXI-CLAV TABLET | 125MG 875MG | TABLET | Resolved | 2023-11-20 | 2023-12-12 | 210829 |
| SANDOZ AMOXI-CLAV TABLET | 125MG 875MG | TABLET | Resolved | 2024-01-23 | 2024-02-06 | 217029 |
| SANDOZ AMOXI-CLAV TABLET | 125MG 875MG | TABLET | Resolved | 2024-02-12 | 2024-04-04 | 219213 |
| SANDOZ AMOXI-CLAV TABLET | 125MG 500MG | TABLET | Resolved | 2024-09-16 | 2025-01-28 | 237732 |
| SANDOZ AMOXI-CLAV TABLET | 875MG 125MG | TABLET | Resolved | 2025-11-10 | 2025-12-01 | 271364 |
| SANDOZ AMPHETAMINE XR | 3.75MG 3.75MG 3.75MG 3.75MG | CAPSULE (EXTENDED RELEASE) | Resolved | 2017-05-08 | 2017-09-07 | 9451 |
| SANDOZ AMPHETAMINE XR | 5MG 5MG 5MG 5MG | CAPSULE (EXTENDED RELEASE) | Resolved | 2018-08-29 | 2018-11-04 | 59546 |
| SANDOZ AMPHETAMINE XR | 7.5MG 7.5MG 7.5MG 7.5MG | CAPSULE (EXTENDED RELEASE) | Resolved | 2018-08-29 | 2019-01-16 | 59549 |
Discontinuation reports
| Brand name | Strength | Dosage | Status | Date Created | Date Updated | Reports |
|---|---|---|---|---|---|---|
| TOBRAMYCIN INHALATION SOLUTION | 300MG | SOLUTION | Discontinued | 2021-09-02 | 2021-09-02 | 145015 |
| VITAMIN B12 | 100MCG | LIQUID | Discontinued | 2017-06-06 | 2017-07-01 | 12133 |
| ZOFRAN ODT | 8MG | TABLET (ORALLY DISINTEGRATING) | Discontinued | 2022-12-08 | 2023-03-14 | 177540 |
| ZOFRAN ODT | 4MG | TABLET (ORALLY DISINTEGRATING) | Discontinued | 2023-03-14 | 2023-03-14 | 187062 |